Publications

2007

Heuzé M.L., Lamsoul I., Moog-Lutz C. and Lutz P.G. (2007). Ubiquitin-mediated proteasomal degradation in normal and malignant hematopoiesis. Blood Cells Mol. Dis., in press.

2005

Heuzé, M.L., Guibal, F.C., Banks, C.A., Conaway, J.W., Conaway, R.C., Cayre, Y.E., Benecke, A., and Lutz, P.G. (2005). ASB2 is an elongin BC-interacting protein that can assemble with cullin 5 and rbx1 to reconstitute an E3 ubiquitin ligase complex. J. Biol. Chem., 280, 5468-5474.

Denis, F.M., Benecke, A., Di Gioia, Y., Touw, I.P., Cayre, Y.E., and Lutz, P.G. (2005). PRAM-1 potentiates arsenic trioxide-induced JNK activation. J. Biol. Chem., 280, 9043-9048.

2003

 Moog-Lutz, C., Cavé-Riant, F., Guibal, F.C., Breau, M.A., Di Gioia, Y., Couraud, P.O., Cayre, Y.E., Bourdoulous, S., and Lutz, P.G. (2003). JAML, a novel protein with characteristics of a Junctional Adhesion Molecule, is induced during differentiation of myeloid leukemia cells. Blood, 102, 3371-3378.

2002

Guibal, F.C., Moog-Lutz, C., Smolewski, P., Di Gioia, Y., Darzynkiewicz, Z., Lutz, P.G., and Cayre, Y.E. (2002). ASB-2 inhibits growth and promotes commitment in myeloid leukemia cells. J. Biol. Chem., 277, 218-224.

Lutz, P.G., Moog-Lutz, C., and Cayre, Y.E. (2002). Signaling revisited in acute promyelocytic leukemia [review]. Leukemia, 16, 1933-1939.